Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vandel

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
Journal of Neurology|September 26, 2012
Logopenic syndrome in posterior cortical atrophyEloi Magnin, Geraldine Sylvestre, Flora Lenoir, et al.
Frontiers in Psychology|October 22, 2021
Cognitive Impairment in Late-Life Depression: A Comparative Study of Healthy Older People, Late-Life Depression, and Mild Alzheimer's Disease Using Multivariate Base Rates of Low ScoresCaroline Masse, Pierre Vandel, Géraldine Sylvestre, et al.
Schizophrenia Research|June 29, 2014
Metacognitive training for schizophrenia: a multicentre randomised controlled trialMalick Briki, Julie Monnin, Emmanuel Haffen, et al.
Alzheimer'S Research & Therapy|June 29, 2017
Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worseFrédéric Blanc, Rachid Mahmoudi, Thérèse Jonveaux, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 25, 2025
Affective Symptoms and Amyloid Plaques: Antidepressant Response and Clinical Outcome Associated With Brain Amyloid Load in a 2-Year Cohort of Nondemented Older Adults With Depression-The ASAP StudyThomas Desmidt, Maria-Joao Santiago-Ribeiro, Gabriel Robert, et al.
Brain, Behavior, and Immunity|August 7, 2013
Leukocyte telomere length in mastocytosis: correlations with depression and perceived stressSophie Georgin-Lavialle, Daniela Silva Moura, Julie Bruneau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2018
Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkersOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR studyOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 26, 2026
Optimizing Antidepressant Use in Geriatric Depression: Expert Consensus from French societies of geriatrics, old age psychiatry and clinical pharmacy (SFGG, SF3PA and SFPC)Morgane Houix, Alexis Lepetit, Christophe Arbus, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
Journal of Neurology|September 26, 2012
Logopenic syndrome in posterior cortical atrophyEloi Magnin, Geraldine Sylvestre, Flora Lenoir, et al.
Frontiers in Psychology|October 22, 2021
Cognitive Impairment in Late-Life Depression: A Comparative Study of Healthy Older People, Late-Life Depression, and Mild Alzheimer's Disease Using Multivariate Base Rates of Low ScoresCaroline Masse, Pierre Vandel, Géraldine Sylvestre, et al.
Schizophrenia Research|June 29, 2014
Metacognitive training for schizophrenia: a multicentre randomised controlled trialMalick Briki, Julie Monnin, Emmanuel Haffen, et al.
Alzheimer'S Research & Therapy|June 29, 2017
Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worseFrédéric Blanc, Rachid Mahmoudi, Thérèse Jonveaux, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 25, 2025
Affective Symptoms and Amyloid Plaques: Antidepressant Response and Clinical Outcome Associated With Brain Amyloid Load in a 2-Year Cohort of Nondemented Older Adults With Depression-The ASAP StudyThomas Desmidt, Maria-Joao Santiago-Ribeiro, Gabriel Robert, et al.
Brain, Behavior, and Immunity|August 7, 2013
Leukocyte telomere length in mastocytosis: correlations with depression and perceived stressSophie Georgin-Lavialle, Daniela Silva Moura, Julie Bruneau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2018
Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkersOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR studyOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 26, 2026
Optimizing Antidepressant Use in Geriatric Depression: Expert Consensus from French societies of geriatrics, old age psychiatry and clinical pharmacy (SFGG, SF3PA and SFPC)Morgane Houix, Alexis Lepetit, Christophe Arbus, et al.
Pageof 9